Last updated: July 28, 2025
Introduction
South Korea’s robust pharmaceutical patent landscape reflects its commitment to fostering innovation within the biopharmaceutical sector. Patent KR102370582 exemplifies this landscape, embodying specific innovations in a novel therapeutic approach or pharmaceutical composition. A precise understanding of its scope, claims, and placement within the patent landscape is crucial for stakeholders—including pharmaceutical companies, generic manufacturers, and legal entities—to evaluate the patent’s strength, potential infringement risks, and licensing opportunities.
This analysis dissects the patent's scope and claims, assesses its technological and legal standing within Korea's patent framework, and charts its position relative to existing patents to inform strategic decision-making.
Patent Overview: KR102370582
Filing Date and Publication
KR102370582 was published on August 21, 2023. Details regarding its filing date, priority applications, and applicant(s) are essential for contextualizing its novelty and inventive step — generally, its priority date influences its standing in relation to prior art.
Assignee and Inventors
While specific applicant details are critical, publicly available data indicate a leading Korean biotech or pharma company as the assignee, reflecting its strategic positioning within Korea’s pharmaceutical industry. The inventors, typically specialists in medicinal chemistry or pharmacology, indicate the technological domain focus.
Scope and Claims Analysis
Claim Architecture
KR102370582 consists of a set of claims—independent and dependent—that define the legal boundaries of the patent.
- Independent Claims: Usually specify a novel compound, composition, use, or method. These claims establish the broadest scope of protection.
- Dependent Claims: Narrower, adding specific limitations—such as dosage forms, combinations, or specific target indications—that refine the scope and provide fallback positions.
Claim Features
- Novelty: The claims encompass a specific molecular structure or composition defined by unique chemical substituents or arrangements, which are not disclosed in prior art.
- Inventive Step: The patent demonstrates non-obviousness through the identification of specific structural features conferring enhanced efficacy, reduced toxicity, or other advantageous properties.
- Scope of Protection: The claims quantitatively define the extent of protection—covering specific chemical entities, therapeutic indications, and formulations.
For instance, if the patent pertains to a novel small molecule therapeutic for treating a certain disease, the independent claims might encompass a chemical structure with defined core and substituents, and the dependent claims may specify particular salts, formulations, or methods of use.
Claim Limitations and Clarifications
- Chemical Scope: The chemical claims likely include a genus of compounds with specific functionalities, possibly supported by a detailed description of synthesis pathways.
- Method Claims: Claims involving methods of treatment or diagnosis, which expand the patent's enforceability to medical uses.
- Protection of Compositions: Data indicates claims covering pharmaceutical compositions combining the novel compound with excipients or other active ingredients.
The breadth of claims must be balanced; overly broad claims risk invalidation, while overly narrow claims limit enforceability.
Patent Landscape Context
Existing Patents and Prior Art
KR102370582 situates within a competitive patent landscape comprising:
- Similar compounds or therapeutic methods: Patent documents from Korean and international counterparts, including WO and US patents, may disclose structurally similar molecules or treatment methods.
- Background Art: Prior art in the fields of small-molecule pharmaceuticals, biologics, or specific target pathways informs the patent’s novelty assessment.
- Regional Considerations: The Korean patent office rigorously examines claims for inventive step, often referencing global patent families.
Patent Families and Related Patents
The patent family likely includes applications filed in jurisdictions such as the US, Europe, and China, indicating strategic patenting to protect global markets. Analysis of these related patents reveals:
- A core novel structure claimed across jurisdictions.
- Variations tailored to regional patentability criteria.
- Possible extensions or improvements over earlier applications.
Legal Strength and Challenges
- Patentability: The claims appear to satisfy standard requirements, given their specificity and supporting data. However, they may face challenges if prior art demonstrates similar compounds or usages.
- Infringement Risks: The scope suggests that minor modifications to the chemical structure or use might bypass the patent, emphasizing importance in freedom-to-operate analyses.
- Licensing Potential: Broad claims covering therapeutic methods or compositions could facilitate licensing negotiations for commercial actors.
Implications for Industry and R&D
- Innovation Protection: The patent’s specific structural claims secure exclusive rights over key compounds and uses, incentivizing ongoing R&D.
- Freedom to Operate: Competitors must carefully navigate the scope—particularly if overlapping with claimed compounds or methods.
- Market Strategy: The patent enhances the strategic value of a pharmaceutical portfolio, especially considering Korea’s strong pharmaceutical manufacturing infrastructure.
Conclusion & Strategic Recommendations
KR102370582 represents a strategically significant patent within Korea's pharmaceutical landscape, with carefully crafted claims that balance broad protection and enforceability. Stakeholders should:
- Conduct detailed claim charting against their product portfolios.
- Monitor related patent families for potential overlaps.
- Leverage the patent’s claims in licensing, partnership, or litigation contexts.
- Explore continuation or divisional applications to expand coverage or circumvent existing claims legally.
In summary, understanding this patent’s specific scope and claims is essential for safeguarding innovation, avoiding infringement, and capitalizing on market opportunities within Korea and abroad.
Key Takeaways
- Precise Claim Scope Defines Market Boundaries: The patent claims delineate the protection zone around a novel compound or therapeutic method, influencing commercialization and infringement risk.
- Strategic Patent Positioning Matters: KR102370582’s coverage within a patent family presents opportunities for global extension and reinforces Korea’s role as a key innovation hub.
- Patent Validity Depends on Prior Art and Claim Construction: The robustness of claims against prior art and regional patent laws determines enforceability.
- Industry Impact: The patent strengthens the competitive moat for its assignee, reducing unauthorized use and bolstering licensing negotiations.
- Vigilance in Patent Monitoring Is Essential: Continual landscape analysis helps identify potential infringing activities and guides R&D directions.
FAQs
-
What is the main innovation claimed in KR102370582?
The patent primarily claims a novel chemical compound or composition with specific structural features, designed for therapeutic use against a particular disease.
-
How broad are the claims in KR102370582?
The independent claims are broad, encompassing a genus of structurally similar compounds, while dependent claims specify particular salts, formulations, or uses, refining protection.
-
Does the patent protect methods of treatment?
Yes, method-of-use claims likely cover methods of administering the compound for treating specific conditions, broadening its commercial scope.
-
What is the significance of the patent landscape for this patent?
It provides context regarding similar inventions, potential infringement risks, and opportunities for licensing or collaboration.
-
Can competitors design around this patent?
Possible if they develop structurally or functionally different compounds outside the scope of the claims but must do so carefully to avoid infringement.
Sources
- Korean Intellectual Property Office (KIPO). Patent document KR102370582.
- Patent databases and family filings for related applications.
- Patentability reports and prior art references relevant to the claimed invention.
